Cambridge, MA, May 14, 2019 — The University of Rochester Medical Center (URMC), one of the nation’s leading academic medical centers, announced it has joined the TriNetX network to expand its access to advanced clinical trials.
“Our goal is to bring high quality, cutting edge clinical trials to URMC for the benefit of our community,” said Dr. Martin Zand, MD, PhD, Professor of Medicine and Public Health Sciences,
Senior Associate Dean for Clinical Research, Co-Director, Clinical and Translational Science Institute, URMC. “We joined TriNetX to greatly expand our access to such trials. We were very impressed with TriNetX’s cohort discovery platform, which many other academic medical centers are using internally and collaboratively for research and quality improvement projects.”
TriNetX has partnered with healthcare organizations (HCO) spanning 23 countries and thousands of sites, and with data providers covering 99% of US health plans to deploy a linked and continually updated global health research network representing over 300 million patients. TriNetX has been used to analyze over 16,000 protocols and has presented over 4,190 clinical trial opportunities to its HCO members.
“TriNetX provided outstanding technical business process support to help get us up and running,” said Dr. Zand. “Within the first week we were presented with two trials that exactly matched our primary areas of therapeutic interest. We share the vision of the TriNetX network which is to enable better and faster access to clinical trials, use technology to remove the barriers of cohort discovery, and connect research centers for collaboration.”
URMC has nearly 3,000 people dedicated to scientific research with over 1,000 clinical trials currently ongoing. Their researchers are studying common and rare illnesses from cancer and heart disease to Parkinson’s and pandemic influenza.
“We are pleased that the URMC has chosen to join the TriNetX network,” said Steve Lethbridge, Senior Vice President of Global Data Networks at TriNetX. “Their efforts have led to therapies that have saved countless lives and have improved human health both in the New York region and across the globe. We look forward to enabling them to expand their research efforts even further.”
About the University of Rochester Medical Center
URMC is a private, coeducational, nonsectarian, and nonprofit research university. The medical center includes the 846-bed Strong Memorial Hospital, the Eastman Institute for Oral Health, and the University’s School of Medicine and Dentistry, Medical Faculty Group, and School of Nursing. For more information, visit URMC at https://www.urmc.rochester.edu/.
TriNetX is the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought. The TriNetX platform is HIPAA and GDPR compliant. For more information, visit TriNetX at https://open.tnxdev.com/ or follow @TriNetX on Twitter.
Susanne Pallo, PhD